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Summary A mail survey among 970 physicians from different specialties was carried out in Italy to learn
about factors that influence physicians' decision-making for patients with early breast cancer. Ninety percent
of respondents were in favour of a conservative procedure for the surgical treatment of a 35-year-old patient
with primary tumour smaller than two centimeters. The same preference was also expressed by 66% of
doctors for a 60-year-old patient with similar disease. Most physicians (78%) favoured the use of adjuvant
chemotherapy for premenopausal node-positive women. Preferences for the treatment of post-menopausal
patients were divided among those in favour of endocrine therapy (51%), chemotherapy (32%), the
combination of the two (7%) or no further treatment after surgery (8%). Several factors appeared to relate to
therapeutic preferences. Each physician's specialty was the single most important factor associated with the
preference for surgical treatment together with the attitude towards patients' involvement in decision-making
which, however, was statistically significant only for the older patient. Analysis of predictors of preferences
for adjuvant therapy showed that specialty and hospital size were associated with choosing chemotherapy for
a premenopausal woman, and specialty and physician's sex with the indication of endocrine treatment in a
postmenopausal patient. Our study documents that the application of research results depends on many
factors, some of which have a sound scientific basis while others reflect highly personal opinions and the
influence of the practice environment.
The treatment of early breast cancer is controversial. In the
last two decades important knowledge of the biology of the
disease has been gained and has led to new treatment
principles.
Results of several randomized controlled trials (RCT) and
case-series studies now indicate that less mutilating surgical
techniques (i.e., lumpectomy and/or quadrantectomy) can
yield similar results in terms of survival as the traditional
radical (Halsted) or modified radical procedures (Patey) in
patients with small primary tumours (Veronesi et al., 1981;
Fisher et al., 1985; Montague, 1984). The several dozen
RCTs on the efficacy of adjuvant chemotherapy and endo-
crine treatment and recent meta-analyses of their results
(Editorial, 1984; Himmel et al., 1986) have led to authori-
tative recommendations (Consensus Conference, 1985) for
their use in routine medical practice for specific subsets of
patients; chemotherapy being recommended for pre- and
tamoxifen for most post-menopausal women except those
with negative oestrogen receptor status, for whom the choice
was left to the treating physicians.
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Despite this increasing consensus, the merits of these
alternative treatments are still among the most controversial
in cancer care and there is evidence that institutional- and
physician-related factors influence how these results are
accepted by doctors (Gazet et al., 1985; Liberati et al., 1987).
To learn about determinants of medical decision making
and the impact of clinical trial results on general practice, we
designed this study to evaluate the importance of certain
factors which lead physicians to prefer one mode of therapy
for breast cancer over another. The results of recent
controlled clinical trials do indeed appear to have shaped
physician's attitudes on the efficacy of different treatments,
but physician's and institutional characteristics are also
important modifiers of the relation beween knowledge and
practice.
Methods
Sampling ofphysicians and response rates
The survey was conducted on a sample of hospital-based
physicians over the period October 1986-June 1987. A
written questionnaire (described below) was used to ascertain
their preferences for limited or radical procedures in treating
clinical stage I breast cancer in two hypothetical patients
aged 35 and 60 years, and for the use of adjuvant treat-
ment(s) - either chemotherapy or hormone therapy - in
treating pathologic stage II breast cancer in the same two
patients.
Out of 60 centres taking part in an existing monitoring
program on quality of cancer care (GIVIO 1986a), 39 (65%)
agreed to cooperate in the present study. Participating and
non-participating hospitals were similar in terms of their size
(median number of beds 888 and 870, respectively) and
organization for the care of cancer patients (35% of both
groups had radiotherapy facilities on site and an oncology
department was present in 20% and 30% of participating
and non-participating centres, respectively).
Nine hundred and seventy physicians from the following
specialties were identified: 427 (44%) were surgeons, 298
(31%) internists, 88 (9%) radiotherapists, 81 (8%) gynaeco-
logists and 71 (7%) medical oncologists, 5 specialty
unknown; 861 (89%) were men and 109 (11%) women.
Of the 970 questionnaires, 657 (68%) were returned; 460
(48%) were fully evaluable and 197 (20%) were from
physicians not seeing patients with breast cancer; 313 (32%)
were not returned. Participation rates varied widely between
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hospitals, the median participation rate being 70% (range
40%-94%).
Specialty was the only significant difference between
respondents and non-respondents: surgeons had the lowest
response rate (60%) compared to internists (68%), gynae-
cologists (74%), radiotherapists (84%) and oncologists
(89%). Participation tended to be slightly higher, though not
significantly so, among younger and female physicians.
A random sample of 95 non-respondents (accounting for
31% of this group) was identified and a telephone interview
attempted to ascertain why they had not returned the
questionnaire and to elicit, whenever possible, their opinions
on the four clinical scenarios. Of the 67 (71%) successfully
traced, 42 (63%) stated that they did not see patients with
breast cancer. The remaining 24 (36%) indicated therapeutic
preferences for the younger pre-menopausal patient fully
comparable to the answers obtained from the respondents to
the mail questionnaire. For the 60-year-old patient, however,
preferences for radical surgery and adjuvant chemotherapy
were slightly more common among the non-respondents.
The questionnaire
The questionnaire was initially delivered directly to indivi-
dual physicians by the data manager at each hospital
together with an explanatory letter and a stamped returned
envelope. Three subsequent follow-up mailings to non-
respondents were made centrally.
In addition to information on preferences, basic demo-
graphic data related to characteristics of the hospital in which
the physician practised and to his/her own personal charac-
teristics were requested. The following hospital-related vari-
ables were explored: (a) size (number of beds); (b) presence
of oncology services (i.e. radiotherapy facilities and oncology
department/ward) on site.
The following physician characteristics were investigated:
(a) specialty; (b) number of breast cancer patients seen by
the physician respondent in 1985; (c) referral patterns (i.e.
whether the physician refers patients to other specialists or
treats them directly).
The questionnaire described four scenarios, two dealing
with treatment of a primary breast lesion and two with post-
surgical adjuvant treatment. The first scenario was phrased
as follows:
'A 35-year old pre-menopausal patient presents with a
1.5cm diameter mass in the upper outer quadrant of her
right breast. Axillary lymph nodes are clinically negative
and there are no other signs of metastases. Assuming that
whatever blood tests, X-ray examinations, and nuclear
scans you use are negative and that a preliminary biopsy
has established the diagnosis of carcinoma, do you favour
a radical surgical approach or a breast-sparing operation
(limited surgery) combined with primary radiotherapy?
The radical surgical approach would mean a type of
radical mastectomy, while the limited surgery would
involve a quadrantectomy, plus axillary dissection and
radical radiotherapy'.
After checking one of two options (1=I favour a radical
surgical approach; 2=I favour a limited surgical approach),
respondents rated the utility of the alternative treatment
modes in achieving the following outcomes: local control,
disease-free survival, avoidance of morbidity, good cosmetic
results, and long-term survival. A 5-point scale was used for
each outcome: 1=limited surgery plus irradiation is vastly
superior to radical surgery; 5=radical surgery is vastly
superior to limited surgery plus irradiation; 3 =the two
treatment modes are equally effective.
Opinions on the use of adjuvant treatments were then
elicited by continuing the scenario as follows:
'After one of the two primary treatment regimens de-
scribed above, the patient is found to have three of twenty
axillary lymph nodes involved. Please consider now your
opinion about which adjuvant treatment (if any) you
would recommend in this patient?'
After checking whether they would recommend: (a) adju-
vant chemotherapy; (b) adjuvant hormone therapy; (c) both;
(d) none, respondents used the 5-point scale described above
to rate the comparative efficacy of the two treatments for
achieving local control, disease-free survival, avoidance of
morbidity and long-term survival.
A second case presentation included the same clinical
information, the only difference being that the patient was
60 years old instead of 35. The same treatment choices and
efficacy judgments were required.
Patient participation score (PPS)
The final section of the questionnaire contained a series of
phrases designed to measure physicians' attitudes toward
involving patients in treatment decisions. Respondents indi-
cated on 5-point scales the extent to which they agreed or
disagreed with 10 statements such as 'asking patients to
participate in treatment decisions produces unnecessary stress
for them' or 'patients who participate in treatment decisions
are less anxious and depressed during recovery'. The scale
was similar to that already developed and used in a previous
study in the United States (Liberati et al., 1987).
Statements were worded so that for some, agreement
indicated attitudes favouring participation and for others
agreement indicated an unfavourable attitude. A score was
constructed by reversing the coding of negatively worded
statements and summing the ten items. The theoretical range
of scores on the PPS is 10 to 50, the highest value
representing greatest willingness to share in the decision-
making process.
Statistical analysis
The individual effects of several potential determinants (such
as age, sex, specialty, type of practice, numbers of patients,
referral patterns and PPS) on preferences for alternative
treatments was first examined using chi-square tests and
analyses of variance in a series of univariate analyses. The
Mann-Whitney test was used to compare median PPS
(Armitage, 1971).
To test the independence of the apparent relationships, a
multiple logistic regression model was used (Schlesselman,
1982) and coefficients were then transformed into odds ratios
(OR) and their approximate 95% Confidence Intervals (CI),
indicating the probabilities of different categories of determi-
nants under study being associated with therapeutic
preferences.
Results
Patterns of therapeutic preference
The majority of respondents (90%) favoured limited surgery
for a 35-year-old patient, and 66% for the 60-year-old
woman.
Preferences varied markedly across different specialties
indicating that surgeons, and to a lesser extent internists,
were less in favour of a conservative procedure than oncolo-
gists and radiotherapists. Although these differences were
statistically significant in both cases, they were particularly
marked for the older patient (P<0.05 and P<0.01, respecti-
vely) (Figure 1).
The attitude toward patient participation (as measured
by the PPS) was another statistically significant predictor of
surgical preference, particularly for the older patient where
preferences were more scattered. Median PPS of physicians
preferring limited surgery was 17 compared to 15 for those
favouring a more radical procedure (Mann-Whitney
test= -2.64, P<0.01).
In keeping with recent therapeutic recommendations, pre-
ferences for the adjuvant treatments differed for the 35- and
the 60-year-old patient. Adjuvant chemotherapy was indi-
cated by 357 (78%) as treatment of choice for the younger632 TREATMENT OF PRIMARY BREAST CANCER IN ITALY
pre-menopausal patient, hormone therapy by 38 (8%), the
combination of the two by 41 (9%), no further treatment by
17 (4%) and 7 (1%) did not answer. For the post-menopau-
sal patient, however, most physicians favoured hormone
therapy (233, 51%). Among the remainder 146 (32%) recom-
mended chemotherapy, 34 (7%) the combination, 38 (8%)
said that no further treatment was warranted and 9 (2%) did
not answer.
Physicians' specialty was again associated with therapeutic
preferences, indicating that radiotherapists and, to a lesser
extent, medical oncologists were following trial results.
Almost all oncologists and radiotherapists recommended
chemotherapy alone for the younger patient (Figure 2).
For the post-menopausal patient, hormonal treatment
alone was the option indicated by 85% of radiotherapists,
64% of oncologists, 61% of gynaecologists, 49% of intern-
ists and 38% of surgeons (Figure 3).
Preferences for adjuvant chemotherapy in the pre- and
hormone therapy in the post-menopausal patient were more
common among physicians practising at larger hospitals
(P<0.01) and those with greater experience (as indicated by
the reported annual workload) (P<0.01). Finally, younger
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Figure 1 Distribution of preferences for limited surgery by
patient's age in relation to physicians' specialty (EW, 35 years; El,
60 years).
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Figure 2 Distribution of preferences for adjuvant chemotherapy
in a pre-menopausal patient in relation to physicians' specialty.
L3, internists; X, surgeons; L1, radiotherapists; ED, oncologists;
C, gynaecologists.
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Figure 3 Distribution of preferences for endocrine treatment in
a post-menopausal patient in relation to physicians' specialty. 0,
internists; 0, surgeons; E, radiotherapists; X, oncologists; El,
gynaecologists.
(P<0.05) and female (P<0.01) physicians recommended
hormonal treatment more frequently in post-menopausal
patients.
Multivariate analysis
In the multivariate analysis of determinants of preferences
for alternative surgical treatments we looked at the effect of
specialty when all potential determinants were simul-
taneously present in the model. For the 35-year-old woman,
although no longer statistically significant, clear cut differ-
ences emerged between specialties with surgeons more in
favour of a radical procedure than other colleagues (Table
I).
For the 60-year-old patient both specialty and PPS were
strong independent predictors (Table I). Radiotherapists
were less likely to prefer radical surgery than other specia-
lists: OR were 7.6 for surgeons and internists, 5.6 for
gynaecologists and 3.6 for medical oncologists (Table I).
Physicians with higher PPS were significantly less likely to
recommend a radical procedure.
When determinants of therapeutic preferences were investi-
gated for the use of adjuvant treatment in the 35-year-old
patient, specialty and hospital size were statistically signifi-
cant predictors (Table I). A surgeon was only 15% as likely
as a radiotherapist colleague to recommend adjuvant che-
motherapy. Internists and gynaecologists were also less in
favour of the treatment than radiotherapists, but the differ-
ences were not significant. Physicians from larger centres
were 50% more likely to recommend the treatment than
colleagues from smaller hospitals. Both individual and set-
ting-related physician characteristics were related to treat-
ment preferences for the post-menopausal patient (Table I).
Compared to radiotherapists, surgeons were nine and intern-
ists four times more likely to prefer adjuvant chemotherapy.
Being a female physician and working at a hospital with an
in-house radiotherapy facility were, on the other hand,
negative predictors of preferences for it. Female physicians -
independently of specialty - were only one third as likely as
male colleagues to recommend chemotherapy and those
working at hospitals with in-house radiotherapy facilities
were only half as likely to recommend the treatment as those
working at a hospital without it (Table I).
Discussion
Perceptions of what constitutes appropriate treatment for
patients with early breast cancer are changing. Overall, these
changes are in keeping with results of RCTs (Veronesi et al.,
1981; Editorial, 1984; Himel et al., 1986) and official treat-
ment recommendations (Consensus Conference 1985).
Physicians' specialty, however, together with personal and
institutional characteristics, emerged as important modifiers
of this general adherence.
A consistent finding throughout our study is that surgeons
and, to a lesser extent, general internists appeared to follow
the results of trials less closely than their oncologist and
radiotherapist colleagues. A clearer perspective could, how-
ever, emerge on comparing our results with the findings of
pattern of care studies from Italy (GIVIO, 1986a) and
elsewhere (Vana et al., 1981). Relative to surgery, there is
reason to suspect that data from our study probably over-
estimate the actual popularity of limited surgery in general
practice. Recent reports have shown that modified radical
mastectomy (Patey mastectomy) in Italy (GIVIO, 1986a) and
the United States (Vana et al., 1981) and simple mastectomy
in the UK (Greenberg & Stevens, 1986) are the most
frequent types of surgery. Where information on tumour size
was available, the frequency of limited surgery appeared to
be much lower. 'Two recent studies conducted in Italy
showed, for example, that in 1984 fewer than half of the
patients with primary tumour smaller than 2cm were treated
with quadrantectomy (GIVIO, 1986a; Cataliotti et al., 1986).
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Table I Multivariate analysis of physicians characteristics in relation to therapeutic preferences.
Radical surgery in Radical surgery in Chemotherapy in Chemotherapy in
Physicians' a 35-year-old pt a 60-year-old pt a 35-year-old pt a 60-year-old pt
characteristics OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Age 1.7 (0.8- 3.5) 1.2 (0.7- 1.9) 0.8 (0.4- 1.5) 1.1 (0.6- 1.8)
Sex' 1.3 (0.4- 4.0) 0.8 (0.4- 1.7) 0.8 (0.3- 2.3) 0.4 (0.2- 0.9)a
Surgeons2 3.5 (0.8-15.9) 7.5 (1.6-12.4)' 0.2 (0.1-0.6)a 8.7 (3.4-22.1)c
Internists2 2.5 (0.5-13.7) 7.7 (2.6-22.7)c 0.2 (0.1- 1.2) 3.4 (1.4-11.4)b
Oncologists2 1.7 (0.6- 4.4) 3.7 (1.2-11.3)a 1.2 (0.2- 9.2) 1.7 (0.5- 5.6)
Gynaecologists2 1.2 (0.4- 3.6) 5.6 (1.7-18.1)b 1.9 (0.3-11.0) 3.2 (0.9-10.4)
Number of pts 0.99 (0.9- 1.1) 0.97 (0.9- 1.0) 0.96 (0.9- 1.0) 1.0 (0.9- 1.1)
Beds 1.1 (0.9- 1.4) 1.1 (0.9- 1.3) 1.5 (1.2- 1.6)c 0.9 (0.8- 1.1)
Oncologic services3 0.7 (0.3- 1.6) 1.1 (0.6- 1.8) 0.7 (0.3- 1.3) 0.6 (0.3- 1.0)
PPS 0.5 (0.2- 1.5) 0.5 (0.3- 0.9)a 1.3 (0.6- 3.0) 0.8 (0.4- 1.6)
ap<0.05; bp<0.01; CP<0.001; 'Male physicians reference category; 2Radiotherapists reference category; 3Hospitals
with both radiotherapy facilities and oncologic department/ward; For continuous variables odds ratios (OR) were
calculated to represent quantitative estimates of 20 years of age, of 10 points of PPS, of 300 beds of hospital size and
of 50 patients for workload.
A similar mail survey conducted in the United States in 1984
indicated that only 10% and 16% doctors would still favour
radical surgery with TI primary tumour (Liberati et al.,
1987).
Although it is conceivable that a change of practice had
occurred in the three years which elapsed between the two
studies, there is still reason to believe that what we observed
indicates a definite difference between actual and reported
practice. Several reasons may account for this. Besides the
influence of social desirability, that probably led some
doctors to report differently from what they do in practice, it
may well be that technical/organizational problems at the
hospitals (such as access to radiotherapy facilities needed to
complete the primary treatment when quadrantectomy is
performed) or judgements based on individual patient con-
ditions explain the difference.
Although in published trials there is no evidence that
limited surgery is less effective in older patients (Veronesi et
al., 1981; Fisher et al., 1985) - in most randomized trials
patients are eligible up to the age of 70 - some authors have
indicated age as a limiting factor for conservative surgery
(Harris et al., 1984, 1985). Physicians in our study (particu-
larly surgeons) seemed to hold this view and this is clearly
indicated by the fact that most of those favouring a more
radical procedure for the older patient also stated that the
treatment was more effective in terms of survival. Because
limited surgery is more complicated and time-consuming and
is chosen primarily for psychological and cosmetic reasons,
its less frequent indication in an older woman is an indi-
cation that doctors (especially surgeons) may weigh these
problems differently according to patient's age.
That preferences depend upon a number of factors not
always related to scientific evidence is also indicated by the
significant influence on treatment preference of individual
provider's attitudes, measured by the PPS. Although one
may argue that the PPS is only theoretical and its clinical
relevance is open to question, the fact that it was a
significant predictor of the preference for conservative treat-
ment suggests that individual providers' attitudes have an
important relationship to therapeutic behaviour. This rela-
tionship may be particularly strong when consensus is not
clearly established, as in the case of limited surgery in a 60-
year-old patient. The same results emerged in a similar
survey of physicians conducted in the United States in 1984.
There too, surgeons and providers who were more likely to
favour patient involvement in treatment decisions - as
measured by an almost identical composite score
- were
substantially more likely to prefer radical over conservative
surgery both in younger and older patients (Liberati et al.,
1987). As a socio/cultural consideration it is interesting to
note that Italian physicians on the whole appeared less likely
to share the decision-making process with their patients than
their US colleagues, as was indicated by the different PPS
for the two groups (Liberati et al., 1987). The influence of
informed consent regulations, particularly state legislation in
Massachusetts where the US study was conducted, may
partly account for this difference. On the other hand, that
physicians in Italy are reluctant to inform cancer patients of
diagnosis and treatment has been clearly documented in a
recent study (GIVIO, 1986b).
Preferences for adjuvant treatment reflected the agreement
and the disagreement still present in the scientific literature.
Although most physicians favoured the use of adjuvant
chemotherapy for a pre-menopausal patient with positive
axillary nodes, surgeons were still at variance with medical
oncologists and radiotherapists, only 67% of surgeons (vs.
96%) stating that the treatment was indicated. This pattern
seems consistent with data from a survey of surgeons in
England (Gazet et al., 1985) where only a minority expressed
a positive opinion on the value of adjuvant treatment, but
very different from data from the 1984 survey in the United
States where most surgeons, together with their colleagues,
were strongly in favour of the treatment (Liberati et al.,
1987).
Physicians from smaller hospitals, independent of spe-
cialty, were less in favour of chemotherapy. Although it is
generally accepted that the treatment can easily be handled
even in a general practice setting, physicians who do not
have access to oncology services may perceive greater diffi-
culty in administering it.
Acceptance of the recent indication of adjuvant endocrine
treatment as the standard for most post-menopausal patients
with positive nodes (Consensus Conference, 1985) (i.e. those
with positive oestrogen-receptor status) is still not uniform.
It is not easy to explain why here again radiotherapists and
surgeons are at opposite poles (indicating the treatment 85%
and 38% of the time, respectively). On the other hand it is
not surprising that doctors working at larger hositals or at
centres with in-house oncology services adhered better to the
recommendations. It is also interesting how closely these
findings correspond with results of the US survey (Liberati
et al., 1987) where the same institutional characteristics
emerged as significant predictors of preference. Finally, the
greater willingness of female physicians to administer endo-
crine therapy over chemotherapy might be viewed as indica-
ting their greater attention to the side effects of the latter
which, in many physicians' opinions, are not worth the
limited benefits of the treatment.
In conclusion, this study suggests that physicians' prefer-
ences are related to many factors, some of which have a
sound scientific basis while others reflect highly personal
opinions and the environment in which practice is con-634 TREATMENT OF PRIMARY BREAST CANCER IN ITALY
ducted. As evidence from randomized trials is often incon-
clusive and overviews are not always possible or fully
convincing (Simon, 1987), a periodic assessment of opinions
among physicians may contribute to a better understanding
of how clinical evidence can be translated into meaningful
guidelines for clinical practice and to target education pro-
grams more effectively.
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